CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE
4.1. Market Overview
4.1.1 Market Size and Forecast, By Deployment Type
4.2. Cloud Based
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. On Premise
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
CHAPTER 5: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION
5.1. Market Overview
5.1.1 Market Size and Forecast, By Application
5.2. Screening And Diagnosis
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Monitoring And Alerting
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Chronic Disease Management
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Digital Therapeutics
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
5.6. Others
5.6.1. Key Market Trends, Growth Factors and Opportunities
5.6.2. Market Size and Forecast, By Region
5.6.3. Market Share Analysis, By Country
CHAPTER 6: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER
6.1. Market Overview
6.1.1 Market Size and Forecast, By End User
6.2. Hospitals And Clinics
6.2.1. Key Market Trends, Growth Factors and Opportunities
6.2.2. Market Size and Forecast, By Region
6.2.3. Market Share Analysis, By Country
6.3. Home Care Settings
6.3.1. Key Market Trends, Growth Factors and Opportunities
6.3.2. Market Size and Forecast, By Region
6.3.3. Market Share Analysis, By Country
6.4. Others
6.4.1. Key Market Trends, Growth Factors and Opportunities
6.4.2. Market Size and Forecast, By Region
6.4.3. Market Share Analysis, By Country
CHAPTER 7: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY REGION
7.1. Market Overview
7.1.1 Market Size and Forecast, By Region
7.2. North America
7.2.1. Key Market Trends and Opportunities
7.2.2. Market Size and Forecast, By Deployment Type
7.2.3. Market Size and Forecast, By Application
7.2.4. Market Size and Forecast, By End User
7.2.5. Market Size and Forecast, By Country
7.2.6. U.S. Software as a Medical Device (SaMD) Market
7.2.6.1. Market Size and Forecast, By Deployment Type
7.2.6.2. Market Size and Forecast, By Application
7.2.6.3. Market Size and Forecast, By End User
7.2.7. Canada Software as a Medical Device (SaMD) Market
7.2.7.1. Market Size and Forecast, By Deployment Type
7.2.7.2. Market Size and Forecast, By Application
7.2.7.3. Market Size and Forecast, By End User
7.2.8. Mexico Software as a Medical Device (SaMD) Market
7.2.8.1. Market Size and Forecast, By Deployment Type
7.2.8.2. Market Size and Forecast, By Application
7.2.8.3. Market Size and Forecast, By End User
7.3. Europe
7.3.1. Key Market Trends and Opportunities
7.3.2. Market Size and Forecast, By Deployment Type
7.3.3. Market Size and Forecast, By Application
7.3.4. Market Size and Forecast, By End User
7.3.5. Market Size and Forecast, By Country
7.3.6. Germany Software as a Medical Device (SaMD) Market
7.3.6.1. Market Size and Forecast, By Deployment Type
7.3.6.2. Market Size and Forecast, By Application
7.3.6.3. Market Size and Forecast, By End User
7.3.7. France Software as a Medical Device (SaMD) Market
7.3.7.1. Market Size and Forecast, By Deployment Type
7.3.7.2. Market Size and Forecast, By Application
7.3.7.3. Market Size and Forecast, By End User
7.3.8. UK Software as a Medical Device (SaMD) Market
7.3.8.1. Market Size and Forecast, By Deployment Type
7.3.8.2. Market Size and Forecast, By Application
7.3.8.3. Market Size and Forecast, By End User
7.3.9. Italy Software as a Medical Device (SaMD) Market
7.3.9.1. Market Size and Forecast, By Deployment Type
7.3.9.2. Market Size and Forecast, By Application
7.3.9.3. Market Size and Forecast, By End User
7.3.10. Spain Software as a Medical Device (SaMD) Market
7.3.10.1. Market Size and Forecast, By Deployment Type
7.3.10.2. Market Size and Forecast, By Application
7.3.10.3. Market Size and Forecast, By End User
7.3.11. Rest Of Europe Software as a Medical Device (SaMD) Market
7.3.11.1. Market Size and Forecast, By Deployment Type
7.3.11.2. Market Size and Forecast, By Application
7.3.11.3. Market Size and Forecast, By End User
7.4. Asia-Pacific
7.4.1. Key Market Trends and Opportunities
7.4.2. Market Size and Forecast, By Deployment Type
7.4.3. Market Size and Forecast, By Application
7.4.4. Market Size and Forecast, By End User
7.4.5. Market Size and Forecast, By Country
7.4.6. Japan Software as a Medical Device (SaMD) Market
7.4.6.1. Market Size and Forecast, By Deployment Type
7.4.6.2. Market Size and Forecast, By Application
7.4.6.3. Market Size and Forecast, By End User
7.4.7. China Software as a Medical Device (SaMD) Market
7.4.7.1. Market Size and Forecast, By Deployment Type
7.4.7.2. Market Size and Forecast, By Application
7.4.7.3. Market Size and Forecast, By End User
7.4.8. India Software as a Medical Device (SaMD) Market
7.4.8.1. Market Size and Forecast, By Deployment Type
7.4.8.2. Market Size and Forecast, By Application
7.4.8.3. Market Size and Forecast, By End User
7.4.9. Australia Software as a Medical Device (SaMD) Market
7.4.9.1. Market Size and Forecast, By Deployment Type
7.4.9.2. Market Size and Forecast, By Application
7.4.9.3. Market Size and Forecast, By End User
7.4.10. South Korea Software as a Medical Device (SaMD) Market
7.4.10.1. Market Size and Forecast, By Deployment Type
7.4.10.2. Market Size and Forecast, By Application
7.4.10.3. Market Size and Forecast, By End User
7.4.11. Rest of Asia-Pacific Software as a Medical Device (SaMD) Market
7.4.11.1. Market Size and Forecast, By Deployment Type
7.4.11.2. Market Size and Forecast, By Application
7.4.11.3. Market Size and Forecast, By End User
7.5. LAMEA
7.5.1. Key Market Trends and Opportunities
7.5.2. Market Size and Forecast, By Deployment Type
7.5.3. Market Size and Forecast, By Application
7.5.4. Market Size and Forecast, By End User
7.5.5. Market Size and Forecast, By Country
7.5.6. Brazil Software as a Medical Device (SaMD) Market
7.5.6.1. Market Size and Forecast, By Deployment Type
7.5.6.2. Market Size and Forecast, By Application
7.5.6.3. Market Size and Forecast, By End User
7.5.7. Saudi Arabia Software as a Medical Device (SaMD) Market
7.5.7.1. Market Size and Forecast, By Deployment Type
7.5.7.2. Market Size and Forecast, By Application
7.5.7.3. Market Size and Forecast, By End User
7.5.8. South Africa Software as a Medical Device (SaMD) Market
7.5.8.1. Market Size and Forecast, By Deployment Type
7.5.8.2. Market Size and Forecast, By Application
7.5.8.3. Market Size and Forecast, By End User
7.5.9. Rest of LAMEA Software as a Medical Device (SaMD) Market
7.5.9.1. Market Size and Forecast, By Deployment Type
7.5.9.2. Market Size and Forecast, By Application
7.5.9.3. Market Size and Forecast, By End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top Winning Strategies
8.3. Product Mapping Of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top Player Positioning, 2023
CHAPTER 9: COMPANY PROFILES
9.1. MindMaze
9.1.1. Company Overview
9.1.2. Key Executives
9.1.3. Company Snapshot
9.1.4. Operating Business Segments
9.1.5. Product Portfolio
9.1.6. Business Performance
9.1.7. Key Strategic Moves and Developments
9.2. Siemens
9.2.1. Company Overview
9.2.2. Key Executives
9.2.3. Company Snapshot
9.2.4. Operating Business Segments
9.2.5. Product Portfolio
9.2.6. Business Performance
9.2.7. Key Strategic Moves and Developments
9.3. Biofourmis
9.3.1. Company Overview
9.3.2. Key Executives
9.3.3. Company Snapshot
9.3.4. Operating Business Segments
9.3.5. Product Portfolio
9.3.6. Business Performance
9.3.7. Key Strategic Moves and Developments
9.4. BrightInsight, Inc.
9.4.1. Company Overview
9.4.2. Key Executives
9.4.3. Company Snapshot
9.4.4. Operating Business Segments
9.4.5. Product Portfolio
9.4.6. Business Performance
9.4.7. Key Strategic Moves and Developments
9.5. 4S Information Systems Ltd,
9.5.1. Company Overview
9.5.2. Key Executives
9.5.3. Company Snapshot
9.5.4. Operating Business Segments
9.5.5. Product Portfolio
9.5.6. Business Performance
9.5.7. Key Strategic Moves and Developments
9.6. Viz.ai, Inc.
9.6.1. Company Overview
9.6.2. Key Executives
9.6.3. Company Snapshot
9.6.4. Operating Business Segments
9.6.5. Product Portfolio
9.6.6. Business Performance
9.6.7. Key Strategic Moves and Developments
9.7. F. Hoffmann-La Roche Ltd
9.7.1. Company Overview
9.7.2. Key Executives
9.7.3. Company Snapshot
9.7.4. Operating Business Segments
9.7.5. Product Portfolio
9.7.6. Business Performance
9.7.7. Key Strategic Moves and Developments
9.8. Koninklijke Philips N.V.,
9.8.1. Company Overview
9.8.2. Key Executives
9.8.3. Company Snapshot
9.8.4. Operating Business Segments
9.8.5. Product Portfolio
9.8.6. Business Performance
9.8.7. Key Strategic Moves and Developments
9.9. Orthogonal
9.9.1. Company Overview
9.9.2. Key Executives
9.9.3. Company Snapshot
9.9.4. Operating Business Segments
9.9.5. Product Portfolio
9.9.6. Business Performance
9.9.7. Key Strategic Moves and Developments
9.10. Zühlke Engineering AG
9.10.1. Company Overview
9.10.2. Key Executives
9.10.3. Company Snapshot
9.10.4. Operating Business Segments
9.10.5. Product Portfolio
9.10.6. Business Performance
9.10.7. Key Strategic Moves and Developments
LIST OF TABLES
TABLE 1. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 2. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR CLOUD BASED, BY REGION, 2024 - 2033 ($MILLION)
TABLE 3. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR ON PREMISE, BY REGION, 2024 - 2033 ($MILLION)
TABLE 4. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 5. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR SCREENING AND DIAGNOSIS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 6. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR MONITORING AND ALERTING, BY REGION, 2024 - 2033 ($MILLION)
TABLE 7. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR CHRONIC DISEASE MANAGEMENT, BY REGION, 2024 - 2033 ($MILLION)
TABLE 8. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR DIGITAL THERAPEUTICS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 9. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 10. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 11. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 12. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR HOME CARE SETTINGS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 13. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($MILLION)
TABLE 14. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY REGION, 2024 - 2033 ($MILLION)
TABLE 15. NORTH AMERICA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 16. NORTH AMERICA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 17. NORTH AMERICA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 18. NORTH AMERICA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 19. U.S. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 20. U.S. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 21. U.S. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 22. CANADA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 23. CANADA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 24. CANADA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 25. MEXICO SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 26. MEXICO SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 27. MEXICO SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 28. EUROPE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 29. EUROPE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 30. EUROPE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 31. EUROPE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 32. GERMANY SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 33. GERMANY SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 34. GERMANY SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 35. FRANCE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 36. FRANCE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 37. FRANCE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 38. UK SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 39. UK SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 40. UK SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 41. ITALY SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 42. ITALY SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 43. ITALY SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 44. SPAIN SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 45. SPAIN SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 46. SPAIN SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 47. REST OF EUROPE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 48. REST OF EUROPE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 49. REST OF EUROPE SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 50. ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 51. ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 52. ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 53. ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 54. JAPAN SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 55. JAPAN SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 56. JAPAN SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 57. CHINA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 58. CHINA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 59. CHINA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 60. INDIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 61. INDIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 62. INDIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 63. AUSTRALIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 64. AUSTRALIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 65. AUSTRALIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 66. SOUTH KOREA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 67. SOUTH KOREA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 68. SOUTH KOREA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 72. LAMEA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY COUNTRY, 2024 - 2033 ($MILLION)
TABLE 73. LAMEA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 74. LAMEA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 75. LAMEA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 76. BRAZIL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 77. BRAZIL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 78. BRAZIL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 79. SAUDI ARABIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 80. SAUDI ARABIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 81. SAUDI ARABIA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 82. SOUTH AFRICA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 83. SOUTH AFRICA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 84. SOUTH AFRICA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 85. REST OF LAMEA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY DEPLOYMENT TYPE, 2024 - 2033 ($MILLION)
TABLE 86. REST OF LAMEA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY APPLICATION, 2024 - 2033 ($MILLION)
TABLE 87. REST OF LAMEA SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, BY END USER, 2024 - 2033 ($MILLION)
TABLE 88. MINDMAZE : KEY EXECUTIVES
TABLE 89. MINDMAZE : COMPANY SNAPSHOT
TABLE 90. MINDMAZE : OPERATING SEGMENTS
TABLE 91. MINDMAZE : PRODUCT PORTFOLIO
TABLE 92. MINDMAZE : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 93. SIEMENS: KEY EXECUTIVES
TABLE 94. SIEMENS: COMPANY SNAPSHOT
TABLE 95. SIEMENS: OPERATING SEGMENTS
TABLE 96. SIEMENS: PRODUCT PORTFOLIO
TABLE 97. SIEMENS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 98. BIOFOURMIS: KEY EXECUTIVES
TABLE 99. BIOFOURMIS: COMPANY SNAPSHOT
TABLE 100. BIOFOURMIS: OPERATING SEGMENTS
TABLE 101. BIOFOURMIS: PRODUCT PORTFOLIO
TABLE 102. BIOFOURMIS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 103. BRIGHTINSIGHT, INC. : KEY EXECUTIVES
TABLE 104. BRIGHTINSIGHT, INC. : COMPANY SNAPSHOT
TABLE 105. BRIGHTINSIGHT, INC. : OPERATING SEGMENTS
TABLE 106. BRIGHTINSIGHT, INC. : PRODUCT PORTFOLIO
TABLE 107. BRIGHTINSIGHT, INC. : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 108. 4S INFORMATION SYSTEMS LTD, : KEY EXECUTIVES
TABLE 109. 4S INFORMATION SYSTEMS LTD, : COMPANY SNAPSHOT
TABLE 110. 4S INFORMATION SYSTEMS LTD, : OPERATING SEGMENTS
TABLE 111. 4S INFORMATION SYSTEMS LTD, : PRODUCT PORTFOLIO
TABLE 112. 4S INFORMATION SYSTEMS LTD, : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 113. VIZ.AI, INC. : KEY EXECUTIVES
TABLE 114. VIZ.AI, INC. : COMPANY SNAPSHOT
TABLE 115. VIZ.AI, INC. : OPERATING SEGMENTS
TABLE 116. VIZ.AI, INC. : PRODUCT PORTFOLIO
TABLE 117. VIZ.AI, INC. : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 118. F. HOFFMANN-LA ROCHE LTD : KEY EXECUTIVES
TABLE 119. F. HOFFMANN-LA ROCHE LTD : COMPANY SNAPSHOT
TABLE 120. F. HOFFMANN-LA ROCHE LTD : OPERATING SEGMENTS
TABLE 121. F. HOFFMANN-LA ROCHE LTD : PRODUCT PORTFOLIO
TABLE 122. F. HOFFMANN-LA ROCHE LTD : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 123. KONINKLIJKE PHILIPS N.V., : KEY EXECUTIVES
TABLE 124. KONINKLIJKE PHILIPS N.V., : COMPANY SNAPSHOT
TABLE 125. KONINKLIJKE PHILIPS N.V., : OPERATING SEGMENTS
TABLE 126. KONINKLIJKE PHILIPS N.V., : PRODUCT PORTFOLIO
TABLE 127. KONINKLIJKE PHILIPS N.V., : KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 128. ORTHOGONAL: KEY EXECUTIVES
TABLE 129. ORTHOGONAL: COMPANY SNAPSHOT
TABLE 130. ORTHOGONAL: OPERATING SEGMENTS
TABLE 131. ORTHOGONAL: PRODUCT PORTFOLIO
TABLE 132. ORTHOGONAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 133. ZüHLKE ENGINEERING AG: KEY EXECUTIVES
TABLE 134. ZüHLKE ENGINEERING AG: COMPANY SNAPSHOT
TABLE 135. ZüHLKE ENGINEERING AG: OPERATING SEGMENTS
TABLE 136. ZüHLKE ENGINEERING AG: PRODUCT PORTFOLIO
TABLE 137. ZüHLKE ENGINEERING AG: KEY STRATEGIC MOVES AND DEVELOPMENTS
LIST OF FIGURES
FIGURE 1. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALSOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET
FIGURE 10. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET SEGMENTATION, BY DEPLOYMENT TYPE
FIGURE 11. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR CLOUD BASED, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 12. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR ON PREMISE, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 13. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET SEGMENTATION, BY APPLICATION
FIGURE 14. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR SCREENING AND DIAGNOSIS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 15. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR MONITORING AND ALERTING, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 16. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR CHRONIC DISEASE MANAGEMENT, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 17. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR DIGITAL THERAPEUTICS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 18. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 19. GLOBAL SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET SEGMENTATION, BY END USER
FIGURE 20. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 21. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 22. SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($MILLION)
FIGURE 23. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 24. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 25. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 26. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 27. COMPETITIVE DASHBOARD
FIGURE 28. COMPETITIVE HEATMAP: SOFTWARE AS A MEDICAL DEVICE (SAMD) MARKET
FIGURE 29. TOP PLAYER POSITIONING, 2023
FIGURE 30. MINDMAZE : NET SALES, 2021-2023 ($MILLION)
FIGURE 31. MINDMAZE : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 32. MINDMAZE : REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 33. SIEMENS: NET SALES, 2021-2023 ($MILLION)
FIGURE 34. SIEMENS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 35. SIEMENS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 36. BIOFOURMIS: NET SALES, 2021-2023 ($MILLION)
FIGURE 37. BIOFOURMIS: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 38. BIOFOURMIS: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 39. BRIGHTINSIGHT, INC. : NET SALES, 2021-2023 ($MILLION)
FIGURE 40. BRIGHTINSIGHT, INC. : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 41. BRIGHTINSIGHT, INC. : REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 42. 4S INFORMATION SYSTEMS LTD, : NET SALES, 2021-2023 ($MILLION)
FIGURE 43. 4S INFORMATION SYSTEMS LTD, : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 44. 4S INFORMATION SYSTEMS LTD, : REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 45. VIZ.AI, INC. : NET SALES, 2021-2023 ($MILLION)
FIGURE 46. VIZ.AI, INC. : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 47. VIZ.AI, INC. : REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 48. F. HOFFMANN-LA ROCHE LTD : NET SALES, 2021-2023 ($MILLION)
FIGURE 49. F. HOFFMANN-LA ROCHE LTD : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 50. F. HOFFMANN-LA ROCHE LTD : REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 51. KONINKLIJKE PHILIPS N.V., : NET SALES, 2021-2023 ($MILLION)
FIGURE 52. KONINKLIJKE PHILIPS N.V., : REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 53. KONINKLIJKE PHILIPS N.V., : REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 54. ORTHOGONAL: NET SALES, 2021-2023 ($MILLION)
FIGURE 55. ORTHOGONAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 56. ORTHOGONAL: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 57. ZüHLKE ENGINEERING AG: NET SALES, 2021-2023 ($MILLION)
FIGURE 58. ZüHLKE ENGINEERING AG: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 59. ZüHLKE ENGINEERING AG: REVENUE SHARE, BY REGION, 2023 (%)
